Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2022

01-02-2022 | Care | Commentary

Commentary: how person-centred is pharmaceutical care?

Authors: Hanna Gyllensten, Joanne M. Fuller, Malin Johansson Östbring

Published in: International Journal of Clinical Pharmacy | Issue 1/2022

Login to get access

Abstract

Health systems in many countries are currently undergoing an evolution towards more person-centred care. However, an overview of the literature shows that there is little or no guidance available on how to apply person-centred care to pharmaceutical care and clinical pharmacy practices. In this paper we apply a model for person-centred care created by a national multidisciplinary research centre in Gothenburg, Sweden, to the clinical work tasks of outpatient and inpatient pharmacists and describe how pharmaceutical care can become more person-centred.
Literature
2.
go back to reference Nolte E, Merkur S, Anell A, European Observatory on Health Systems and Policies, editors. Achieving person-centred health systems: evidence, strategies and challenges. Cambridge ; New York, NY: Cambridge University Press; 2020. ISBN: 978–1–108–79006–2 Nolte E, Merkur S, Anell A, European Observatory on Health Systems and Policies, editors. Achieving person-centred health systems: evidence, strategies and challenges. Cambridge ; New York, NY: Cambridge University Press; 2020. ISBN: 978–1–108–79006–2
3.
go back to reference Håkansson Eklund J, Holmström IK, Kumlin T, et al. “Same same or different?” A review of reviews of person-centered and patient-centered care. Patient Educ Couns. 2019;102:3–11.CrossRef Håkansson Eklund J, Holmström IK, Kumlin T, et al. “Same same or different?” A review of reviews of person-centered and patient-centered care. Patient Educ Couns. 2019;102:3–11.CrossRef
4.
go back to reference Rosengren K, Brannefors P, Carlström E. Adoption of the concept of Person-centred care into discourse in Europe: A systematic literature review. J Health Organ Manag. 2021;[accepted for publication 17 Jul 2021]. Rosengren K, Brannefors P, Carlström E. Adoption of the concept of Person-centred care into discourse in Europe: A systematic literature review. J Health Organ Manag. 2021;[accepted for publication 17 Jul 2021].
5.
go back to reference Britten N, Ekman I, Naldemirci Ö, et al. Learning from Gothenburg model of person centred healthcare. BMJ. 2020;370:m2738. Britten N, Ekman I, Naldemirci Ö, et al. Learning from Gothenburg model of person centred healthcare. BMJ. 2020;370:m2738.
6.
go back to reference Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed
7.
go back to reference Galt KA. The Need to Define “Care” in pharmaceutical care: an examination across research, practice and education. Am J Pharm Educ. 2000;64:223–33. Galt KA. The Need to Define “Care” in pharmaceutical care: an examination across research, practice and education. Am J Pharm Educ. 2000;64:223–33.
8.
go back to reference Developed through the ASHP Council on Pharmacy Practice and approved by the ASHP Board of Directors on April 13, 2012, and by the ASHP House of Delegates on June 10, 2012. ASHP statement on the pharmacist’s role in medication reconciliation. Am J Health Syst Pharm. 2013;70:453–6. Developed through the ASHP Council on Pharmacy Practice and approved by the ASHP Board of Directors on April 13, 2012, and by the ASHP House of Delegates on June 10, 2012. ASHP statement on the pharmacist’s role in medication reconciliation. Am J Health Syst Pharm. 2013;70:453–6.
9.
go back to reference Gernant SA, Bacci JL, Upton C, et al. Three opportunities for standardization: a literature review of the variation among pharmacists’ patient care services terminology. Res Social Adm Pharm. 2020;16:766–75.CrossRef Gernant SA, Bacci JL, Upton C, et al. Three opportunities for standardization: a literature review of the variation among pharmacists’ patient care services terminology. Res Social Adm Pharm. 2020;16:766–75.CrossRef
10.
go back to reference Uzman N, Kusynova Z, Manikkath J, et al. Making the profession attractive for our future and young pharmacists, the game changers for primary health care. J Pharm Pract Res. 2019;49:373–5.CrossRef Uzman N, Kusynova Z, Manikkath J, et al. Making the profession attractive for our future and young pharmacists, the game changers for primary health care. J Pharm Pract Res. 2019;49:373–5.CrossRef
11.
go back to reference Rathbone AP, Jamie K. Transferring from clinical pharmacy practice to qualitative research: questioning identity, epistemology and ethical frameworks. Soc Res Online. 2016;21:1–9.CrossRef Rathbone AP, Jamie K. Transferring from clinical pharmacy practice to qualitative research: questioning identity, epistemology and ethical frameworks. Soc Res Online. 2016;21:1–9.CrossRef
12.
go back to reference de Almeida NY, Ramalho-de-Oliveira D. The subjective experience of using medications: what we know and the paths forward. Pharmacy (Basel). 2021;9:50. de Almeida NY, Ramalho-de-Oliveira D. The subjective experience of using medications: what we know and the paths forward. Pharmacy (Basel). 2021;9:50.
13.
go back to reference Møller M, Herborg H, Andersen SE, et al. Chronic medicine users’ self-managing medication with information - A typology of patients with self-determined, security-seeking and dependent behaviors. Res Social Adm Pharm. 2021;17:750–62.CrossRef Møller M, Herborg H, Andersen SE, et al. Chronic medicine users’ self-managing medication with information - A typology of patients with self-determined, security-seeking and dependent behaviors. Res Social Adm Pharm. 2021;17:750–62.CrossRef
14.
go back to reference Denford S, Frost J, Dieppe P, et al. Individualisation of drug treatments for patients with long-term conditions: a review of concepts. BMJ Open. 2014;4:e004172.CrossRef Denford S, Frost J, Dieppe P, et al. Individualisation of drug treatments for patients with long-term conditions: a review of concepts. BMJ Open. 2014;4:e004172.CrossRef
15.
go back to reference Markgren R, Brännström M, Lundgren C, et al. Impacts of person-centred integrated chronic heart failure and palliative home care on pharmacological heart failure treatment: a substudy of a randomised trial. BMJ Support Palliat Care. 2019;9:e10.CrossRef Markgren R, Brännström M, Lundgren C, et al. Impacts of person-centred integrated chronic heart failure and palliative home care on pharmacological heart failure treatment: a substudy of a randomised trial. BMJ Support Palliat Care. 2019;9:e10.CrossRef
16.
go back to reference Sabaté E, World Health Organization, editors. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. ISBN: 978–92–4–154599–0 Sabaté E, World Health Organization, editors. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. ISBN: 978–92–4–154599–0
17.
go back to reference Easthall C, Song F, Bhattacharya D. A meta-analysis of cognitive-based behaviour change techniques as interventions to improve medication adherence. BMJ Open. 2013;3:e002749.CrossRef Easthall C, Song F, Bhattacharya D. A meta-analysis of cognitive-based behaviour change techniques as interventions to improve medication adherence. BMJ Open. 2013;3:e002749.CrossRef
18.
go back to reference Hedegaard U, Kjeldsen LJ, Pottegård A, et al. Improving medication adherence in patients with hypertension: a randomized trial. Am J Med. 2015;128:1351–61.CrossRef Hedegaard U, Kjeldsen LJ, Pottegård A, et al. Improving medication adherence in patients with hypertension: a randomized trial. Am J Med. 2015;128:1351–61.CrossRef
19.
go back to reference Sieben A, van Onzenoort HA, van Laarhoven KJ, et al. A Multifaceted Nurse- and Web-Based Intervention for Improving Adherence to Treatment in Patients With Cardiovascular Disease: Rationale and Design of the MIRROR Trial. JMIR Res Protoc. 2016;5:e187.CrossRef Sieben A, van Onzenoort HA, van Laarhoven KJ, et al. A Multifaceted Nurse- and Web-Based Intervention for Improving Adherence to Treatment in Patients With Cardiovascular Disease: Rationale and Design of the MIRROR Trial. JMIR Res Protoc. 2016;5:e187.CrossRef
20.
go back to reference Gyllensten H, Björkman I, Jakobsson Ung E, et al. A national research centre for the evaluation and implementation of person-centred care: Content from the first interventional studies. Health Expect. 2020;23:1362–75.CrossRef Gyllensten H, Björkman I, Jakobsson Ung E, et al. A national research centre for the evaluation and implementation of person-centred care: Content from the first interventional studies. Health Expect. 2020;23:1362–75.CrossRef
21.
go back to reference Kempen TGH, Bertilsson M, Hadziosmanovic N, et al. Effects of hospital-based comprehensive medication reviews including postdischarge follow-up on older patients’ use of health care: a cluster randomized clinical trial. JAMA Netw Open. 2021;4:e216303.CrossRef Kempen TGH, Bertilsson M, Hadziosmanovic N, et al. Effects of hospital-based comprehensive medication reviews including postdischarge follow-up on older patients’ use of health care: a cluster randomized clinical trial. JAMA Netw Open. 2021;4:e216303.CrossRef
22.
go back to reference Ravn-Nielsen LV, Duckert M-L, Lund ML, et al. Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission: a randomized clinical trial. JAMA Intern Med. 2018;178:375–82.CrossRef Ravn-Nielsen LV, Duckert M-L, Lund ML, et al. Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission: a randomized clinical trial. JAMA Intern Med. 2018;178:375–82.CrossRef
23.
go back to reference Barnett NL. Guide to undertaking person-centred inpatient (ward) outpatient (clinic) and dispensary-based pharmacy consultations. Eur J Hosp Pharm. 2020;27:302–5.CrossRef Barnett NL. Guide to undertaking person-centred inpatient (ward) outpatient (clinic) and dispensary-based pharmacy consultations. Eur J Hosp Pharm. 2020;27:302–5.CrossRef
25.
go back to reference Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the patient-centered approach to medication management services. 3. ed. New York: McGraw-Hill; 2012. ISBN: 978-0-07-175638-9 Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the patient-centered approach to medication management services. 3. ed. New York: McGraw-Hill; 2012. ISBN: 978-0-07-175638-9
26.
go back to reference Odeh M, Scullin C, Fleming G, et al. Ensuring continuity of patient care across the healthcare interface: telephone follow-up post-hospitalization. Br J Clin Pharmacol. 2019;85:616–25.CrossRef Odeh M, Scullin C, Fleming G, et al. Ensuring continuity of patient care across the healthcare interface: telephone follow-up post-hospitalization. Br J Clin Pharmacol. 2019;85:616–25.CrossRef
27.
go back to reference Swedberg K, Cawley D, Ekman I, et al. Testing cost containment of future healthcare with maintained or improved quality-The COSTCARES project. Health Sci Rep. 2021;4:e309.CrossRef Swedberg K, Cawley D, Ekman I, et al. Testing cost containment of future healthcare with maintained or improved quality-The COSTCARES project. Health Sci Rep. 2021;4:e309.CrossRef
28.
go back to reference Evén G, Spaak J, von Arbin M, et al. Health care professionals’ experiences and enactment of person-centered care at a multidisciplinary outpatient specialty clinic. J Multidiscip Healthc. 2019;12:137–48.CrossRef Evén G, Spaak J, von Arbin M, et al. Health care professionals’ experiences and enactment of person-centered care at a multidisciplinary outpatient specialty clinic. J Multidiscip Healthc. 2019;12:137–48.CrossRef
29.
go back to reference Barenfeld E, Ali L, Wallström S, et al. Becoming more of an insider: A grounded theory study on patients’ experience of a person-centred e-health intervention. PLoS ONE. 2020;15:e0241801.CrossRef Barenfeld E, Ali L, Wallström S, et al. Becoming more of an insider: A grounded theory study on patients’ experience of a person-centred e-health intervention. PLoS ONE. 2020;15:e0241801.CrossRef
30.
go back to reference Syafhan NF, Al Azzam S, Williams SD, et al. General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial. J Pharm Policy Pract. 2021;14:4.CrossRef Syafhan NF, Al Azzam S, Williams SD, et al. General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial. J Pharm Policy Pract. 2021;14:4.CrossRef
31.
go back to reference Kehrer JP, Eberhart G, Wing M, et al. Pharmacy’s role in a modern health continuum. Can Pharm J (Ott). 2013;146:321–4.CrossRef Kehrer JP, Eberhart G, Wing M, et al. Pharmacy’s role in a modern health continuum. Can Pharm J (Ott). 2013;146:321–4.CrossRef
32.
go back to reference Olsson LE, Jakobsson Ung E, Swedberg K, et al. Efficacy of person-centred care as an intervention in controlled trials - a systematic review. J Clin Nurs. 2013;22:456–65.CrossRef Olsson LE, Jakobsson Ung E, Swedberg K, et al. Efficacy of person-centred care as an intervention in controlled trials - a systematic review. J Clin Nurs. 2013;22:456–65.CrossRef
33.
go back to reference Hansson E, Ekman I, Swedberg K, et al. Person-centred care for patients with chronic heart failure - a cost-utility analysis. Eur J Cardiovasc Nurs. 2015;15:276–84.CrossRef Hansson E, Ekman I, Swedberg K, et al. Person-centred care for patients with chronic heart failure - a cost-utility analysis. Eur J Cardiovasc Nurs. 2015;15:276–84.CrossRef
34.
go back to reference Gyllensten H, Koinberg I, Carlström E, et al. Economic evaluation of a person-centred care intervention in head and neck oncology: results from a randomized controlled trial. Support Care Cancer. 2019;27:1825–34.CrossRef Gyllensten H, Koinberg I, Carlström E, et al. Economic evaluation of a person-centred care intervention in head and neck oncology: results from a randomized controlled trial. Support Care Cancer. 2019;27:1825–34.CrossRef
35.
go back to reference Pirhonen L, Bolin K, Olofsson EH, et al. Person-centred care in patients with acute coronary syndrome: cost-effectiveness analysis alongside a randomised controlled trial. Pharmacoecon Open. 2019;3:495–504.CrossRef Pirhonen L, Bolin K, Olofsson EH, et al. Person-centred care in patients with acute coronary syndrome: cost-effectiveness analysis alongside a randomised controlled trial. Pharmacoecon Open. 2019;3:495–504.CrossRef
36.
go back to reference Pirhonen L, Gyllensten H, Fors A, et al. Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome. Eur J Health Econ. 2020;21:1317–27.CrossRef Pirhonen L, Gyllensten H, Fors A, et al. Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome. Eur J Health Econ. 2020;21:1317–27.CrossRef
Metadata
Title
Commentary: how person-centred is pharmaceutical care?
Authors
Hanna Gyllensten
Joanne M. Fuller
Malin Johansson Östbring
Publication date
01-02-2022
Publisher
Springer International Publishing
Keyword
Care
Published in
International Journal of Clinical Pharmacy / Issue 1/2022
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-021-01332-0

Other articles of this Issue 1/2022

International Journal of Clinical Pharmacy 1/2022 Go to the issue

ACKNOWLEDGEMENT

Thank You Reviewers

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine